MP64-06 DOES CHEMOTHERAPY CONFER A SURVIVAL BENEFIT FOR CLINICALLY NEURO-ENDOCRINE CARCINOMA OF THE PROSTATE: LESSONS LEARNT FROM THE REVIEW OF NATIONAL CANCER DATABASE | Zendy

AI Assistant Blog Pricing

MP64-06 DOES CHEMOTHERAPY CONFER A SURVIVAL BENEFIT FOR CLINICALLY NEURO-ENDOCRINE CARCINOMA OF THE PROSTATE: LESSONS LEARNT FROM THE REVIEW OF NATIONAL CANCER DATABASE

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.